Market Trends Arcus stock falls as Gilead opts out cancer drug (RCUS:NYSE)By admin8996erT0allFebruary 18, 2025 kyolshinShares of Arcus Biosciences (NYSE:RCUS) hit a new 52-week low on Tuesday after the biotech said that Gilead Sciences’ (NASDAQ:GILD)…
